1. Home
  2. BCYC vs VLRS Comparison

BCYC vs VLRS Comparison

Compare BCYC & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • VLRS
  • Stock Information
  • Founded
  • BCYC 2009
  • VLRS 2005
  • Country
  • BCYC United Kingdom
  • VLRS Mexico
  • Employees
  • BCYC N/A
  • VLRS N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • VLRS Air Freight/Delivery Services
  • Sector
  • BCYC Health Care
  • VLRS Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • VLRS Nasdaq
  • Market Cap
  • BCYC 566.5M
  • VLRS 546.3M
  • IPO Year
  • BCYC 2019
  • VLRS N/A
  • Fundamental
  • Price
  • BCYC $7.42
  • VLRS $4.18
  • Analyst Decision
  • BCYC Buy
  • VLRS Strong Buy
  • Analyst Count
  • BCYC 10
  • VLRS 6
  • Target Price
  • BCYC $25.00
  • VLRS $8.35
  • AVG Volume (30 Days)
  • BCYC 223.0K
  • VLRS 947.6K
  • Earning Date
  • BCYC 08-05-2025
  • VLRS 07-21-2025
  • Dividend Yield
  • BCYC N/A
  • VLRS N/A
  • EPS Growth
  • BCYC N/A
  • VLRS N/A
  • EPS
  • BCYC N/A
  • VLRS 0.04
  • Revenue
  • BCYC $25,722,000.00
  • VLRS $3,052,207,000.00
  • Revenue This Year
  • BCYC $7.35
  • VLRS $2.04
  • Revenue Next Year
  • BCYC N/A
  • VLRS $12.38
  • P/E Ratio
  • BCYC N/A
  • VLRS $11.58
  • Revenue Growth
  • BCYC N/A
  • VLRS N/A
  • 52 Week Low
  • BCYC $6.10
  • VLRS $3.49
  • 52 Week High
  • BCYC $28.67
  • VLRS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 36.14
  • VLRS 38.06
  • Support Level
  • BCYC $8.33
  • VLRS $4.56
  • Resistance Level
  • BCYC $8.63
  • VLRS $4.66
  • Average True Range (ATR)
  • BCYC 0.50
  • VLRS 0.18
  • MACD
  • BCYC -0.13
  • VLRS -0.06
  • Stochastic Oscillator
  • BCYC 7.18
  • VLRS 0.57

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: